Global Male Infertility Market: Industry Analysis and Forecast 2021-2027: by Test Type, Treatment, and Region

Global Male Infertility Market is anticipated to reach US$ 6.68 Bn by 2027 from US$ 5.04 Bn. in 2019 at a CAGR of 4.8% during a forecast period.

Global Male Infertility Market Overview

Male infertility is described as a male counterpart's inability to induce conception in a fertile female. Male infertility is typically caused by a low sperm count, hormonal issues, or a lack of motile sperm. The brain, pituitary gland, and testes must all operate normally for a male to be fertile. Consumption of alcohol and drugs, growing stress levels, obesity, smoking, and environmental pollutants are some of the other major reasons for male infertility. According to WHO estimates, infertility affects 48 million couples and 186 million people globally. Global Male Infertility Market To know about the Research Methodology :- Request Free Sample Report The report has covered the market trends from 2015 to forecast the market through 2027. 2019 is considered a base year however 2020’s numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Global Male Infertility Market Dynamics

Advances in medical diagnostics, as well as rising male infertility, are driving the demand for male infertility. Infertility due to lifestyle-related disorders, rising obesity and an aging population are also expected to fuel market growth throughout the forecast period. However, as people become more conscious of their health problems and are willing to break through cultural barriers by admitting the reality of male infertility and pursuing treatment options, the market for male infertility treatments is growing. Global Male Infertility Market 1 Continuous research and development efforts are being done to evaluate the condition of idiopathic infertility. As a result, companies are investing in the development of root-cause detection and targeted-treatment technologies. Additionally, the manufacturing and commercialization of hormone treatment are likely to boost demand for male infertility throughout the forecast period. Governments throughout the world have taken measures to improve the outlook for infertility-related therapy. Also, better patient data security as a result of law uniformity is likely to boost consumer demand for infertility therapy. The high cost of therapy is a significant barrier for most who need it. Another limiting element of male infertility treatment is the frequency of recurrent treatment failures, which is leading to the patient opting out of the treatment.

Global Male Infertility Market Segmentation Analysis

By Test Type, The DNA Fragmentation technique is expected to grow steadily in the future, owing to widespread use and the capacity of the diagnostic technique to provide an accurate examination of sperm DNA integrity. One of the primary reasons affecting male infertility is DNA fragmentation in sperm. This method is used to determine male infertility for diagnostic purposes. DNA fragmentation accounted for the biggest market share in 2019, since diagnostic procedures may give a reliable evaluation of sperm DNA integrity. DNA fragmentation is a relatively recent technology that has quickly acquired popularity in developing countries and is now extensively utilized.

Global Male Infertility Market Regional Insights

Europe dominated the market in 2019, with a market share of 31.2 percent, and this dominance is expected to continue during the forecast period. The region's growth is being fueled by an aging population, diseases, and a rising acceptance of less invasive procedures. Furthermore, the existence of a significant number of modern and well-equipped specialist reproductive clinics, as well as manufacturing firms, is expected to fuel market growth in this region. North America is the second-largest male infertility market because of reasons such as growing occurrences of male infertility due to lifestyle variables such as obesity and diet, and technical developments that are meeting necessity treatment. The male infertility market is also benefiting from an increase in medical tourism and homosexuality in the United States. Due to the growing population, increased awareness of male infertility conditions, and readily available treatment options, the Male Infertility Market in the Asia Pacific is expected to grow during the forecast period. Although the government supports the adoption of technological advancements, infertility treatments are rarely covered by private or public insurance policies, restricting access to treatment for low-income people in this region.  

Competitive Landscape

Major players are adopting long-term strategies to acquire competitive advantages, such as new product launches, product upgrades, mergers and acquisitions, and collaboration partnerships. as an example, in June 2020, Inspiration Healthcare agreed to buy S.L.E., a business that designs and manufactures ventilators for neonatal critical care. The purchase might help the firm become a market leader in neonatal critical care. The purchase would also extend the company's product line and global distribution network. Inspiration Healthcare acquired Viomedex, a medical device maker, in December 2019. The purchase extended the company's product line and created prospects for expansion into the neonatal critical care market. Drager cooperated with Florida Hospital in May 2020, after which the latter business deployed Drager's Babyleo TN500 IncuWarmer beds. The beds are in use in three hospitals in Central Florida's health system's Neonatal Intensive Care Units (NICU).

Global Male Infertility Market Scope: Inquire before buying

Global Male Infertility Market 3

Global Male Infertility Market by Region

• North America • Asia pacific • Europe • Middle East and Africa • South America

Global Male Infertility Market: Key Players

Bayer Healthcare, Inc • EMD Sereno • Aytu BioScience, IncHalotech DNA SL • Intas Pharmaceuticals Ltd • Cadila Healthcare Ltd • Andrology Solutions • SCSA diagnostics, Inc • Endo International plc • Vitrolife • Merck KGaA • Access Pharmaceuticals, Inc • Andrology Solutions • ASKA Pharmaceutical Co. Ltd • Cordex Pharma, Inc

Frequently Asked Questions

1. What is the projected market size & growth rate of Global Male Infertility Market? Ans- Male Infertility Market was valued at USD 5.04 billion in 2019 and is projected to reach USD 6.68 billion by 2027, growing at a CAGR of 4.8% during the forecast period. 2. What are the key driving factors for the growth of Global Male Infertility Market? Ans- Advances in medical diagnostics, as well as rising male infertility, are driving the demand for male infertility. Infertility due to lifestyle-related disorders, rising obesity, and an ageing population are also expected to fuel market growth throughout the forecast period. 3. Which region accounted for the largest Global Male Infertility Market share? Ans- Europe dominated the market in 2019, with a market share of 31.3 percent, and this dominance is expected to continue during the forecast period. 4. What makes Asia Pacific a Lucrative Market for Global Male Infertility Market? Ans- Due to growing population, increased awareness of male infertility condition, and readily available treatment options, the Male Infertility Market in Asia Pacific is expected to grow during the forecast period. 5. What are the top players operating in Global Male Infertility Market? Ans- Bayer Healthcare, Inc, EMD Sereno, Aytu BioScience, Inc, Halotech DNA SL, Intas Pharmaceuticals Ltd, Cadila Healthcare Ltd, and Andrology Solutions.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Male Infertility Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Male Infertility Market 3.4. Geographical Snapshot of the Male Infertility Market, By Manufacturer share 4. Global Male Infertility Market Overview, 2019-2027 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Male Infertility Market 5. Supply Side and Demand Side Indicators 6. Global Male Infertility Market Analysis and Forecast, 2019-2027 6.1. Global Male Infertility Market Size & Y-o-Y Growth Analysis. 7. Global Male Infertility Market Analysis and Forecasts, 2019-2027 7.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 7.1.1. DNA Fragmentation Technique 7.1.2. Oxidative Stress Analysis 7.1.3. Sperm Agglutination 7.1.4. Computer Assisted Semen Analysis 7.1.5. Sperm Penetration Assay 7.1.6. others 7.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 7.2.1. Assisted Reproductive Technology & Surgery 7.2.2. Hormone Treatment & Medications 8. Global Male Infertility Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2027 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Male Infertility Market Analysis and Forecasts, 2019-2027 9.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 9.1.1. DNA Fragmentation Technique 9.1.2. Oxidative Stress Analysis 9.1.3. Sperm Agglutination 9.1.4. Computer Assisted Semen Analysis 9.1.5. Sperm Penetration Assay 9.1.6. others 9.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 9.2.1. Assisted Reproductive Technology & Surgery 9.2.2. Hormone Treatment & Medications 10. North America Male Infertility Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Male Infertility Market Analysis and Forecasts, 2019-2027 11.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 11.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 12. Canada Male Infertility Market Analysis and Forecasts, 2019-2027 12.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 12.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 13. Mexico Male Infertility Market Analysis and Forecasts, 2019-2027 13.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 13.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 14. Europe Male Infertility Market Analysis and Forecasts, 2019-2027 14.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 14.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 15. Europe Male Infertility Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Male Infertility Market Analysis and Forecasts, 2019-2027 16.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 16.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 17. France Male Infertility Market Analysis and Forecasts, 2019-2027 17.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 17.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 18. Germany Male Infertility Market Analysis and Forecasts, 2019-2027 18.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 18.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 19. Italy Male Infertility Market Analysis and Forecasts, 2019-2027 19.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 19.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 20. Spain Male Infertility Market Analysis and Forecasts, 2019-2027 20.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 20.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 21. Sweden Male Infertility Market Analysis and Forecasts, 2019-2027 21.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 21.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 22. CIS Countries Male Infertility Market Analysis and Forecasts, 2019-2027 22.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 22.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 23. Rest of Europe Male Infertility Market Analysis and Forecasts, 2019-2027 23.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 23.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 24. Asia Pacific Male Infertility Market Analysis and Forecasts, 2019-2027 24.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 24.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 25. Asia Pacific Male Infertility Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2027 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Male Infertility Market Analysis and Forecasts, 2019-2027 26.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 26.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 27. India Male Infertility Market Analysis and Forecasts, 2019-2027 27.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 27.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 28. Japan Male Infertility Market Analysis and Forecasts, 2019-2027 28.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 28.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 29. South Korea Male Infertility Market Analysis and Forecasts, 2019-2027 29.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 29.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 30. Australia Male Infertility Market Analysis and Forecasts, 2019-2027 30.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 30.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 31. ASEAN Male Infertility Market Analysis and Forecasts, 2019-2027 31.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 31.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 32. Rest of Asia Pacific Male Infertility Market Analysis and Forecasts, 2019-2027 32.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 32.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 33. Middle East Africa Male Infertility Market Analysis and Forecasts, 2019-2027 33.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 33.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 34. Middle East Africa Male Infertility Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Male Infertility Market Analysis and Forecasts, 2019-2027 35.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 35.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 36. GCC Countries Male Infertility Market Analysis and Forecasts, 2019-2027 36.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 36.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 37. Egypt Male Infertility Market Analysis and Forecasts, 2019-2027 37.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 37.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 38. Nigeria Male Infertility Market Analysis and Forecasts, 2019-2027 38.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 38.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 39. Rest of ME&A Male Infertility Market Analysis and Forecasts, 2019-2027 39.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 39.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 40. South America Male Infertility Market Analysis and Forecasts, 2019-2027 40.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 40.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 41. South America Male Infertility Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2027 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Male Infertility Market Analysis and Forecasts, 2019-2027 42.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 42.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 43. Argentina Male Infertility Market Analysis and Forecasts, 2019-2027 43.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 43.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 44. Rest of South America Male Infertility Market Analysis and Forecasts, 2019-2027 44.1. Market Size (Value) Estimates & Forecast By Test Type,2019-2027 44.2. Market Size (Value) Estimates & Forecast By Treatment ,2019-2027 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Male Infertility Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Applications 45.2.3.2. M&A Key Players, Forward Integration and Backward Integration 45.3. Company Profile: Key Players 45.3.1. EMD Sereno 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.4. Bayer Healthcare, Inc 45.5. EMD Sereno 45.6. Aytu BioScience, Inc 45.7. Halotech DNA SL 45.8. Intas Pharmaceuticals Ltd 45.9. Cadila Healthcare Ltd 45.10. Andrology Solutions 45.11. SCSA diagnostics, Inc 45.12. Endo International plc 45.13. Vitrolife 45.14. Merck KGaA 45.15. Access Pharmaceuticals, Inc 45.16. Andrology Solutions 45.17. ASKA Pharmaceutical Co. Ltd 45.18. Cordex Pharma, Inc 46. Primary Key Insights

About This Report

Report ID 117237
Category Healthcare
Published Date Aug 2021
Updated Date
Contact Us